TARILIAN LASER TECHNOLOGIES LIMITED

Dissolved London

Other research and experimental development on natural sciences and engineering

Life sciences and medical technology Other research and experimental development on natural sciences and engineering
T

TARILIAN LASER TECHNOLOGIES LIMITED

Other research and experimental development on natural sciences and engineering

Founded 26 May 2006 Dissolved London, United Kingdom website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

C/O Quantuma Llp High Holborn House 52-54 High Holborn London WC1V 6RL

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for TARILIAN LASER TECHNOLOGIES LIMITED (05830233), a dissolved life sciences and medical technology company based in London, United Kingdom. Incorporated 26 May 2006. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 313,303 Shares £1.48m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 May 20199,567£150k£15.679
6 Aug 201818,615£250k£13.43
6 Aug 20188,547£115k£13.43
31 Jan 20185,434£5.434£0.001
25 Nov 201733,767£33.767£0.001

Officers

Officers

2 active 1 resigned
Status
Nita ShahDirectorBritishUnited Kingdom6226 May 2006Active
Nita ShahSecretaryUnknownUnknown28 Feb 2011Active

Shareholders

Shareholders (1)

Huma Therapeutics Limited
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Nita Shah

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB May 1963
Nature of Control
  • Voting Rights 25 To 50 Percent

Sandeep Shah

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB September 1964
Nature of Control
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2025GazetteGazette Dissolved Liquidation
22 Jan 2025InsolvencyLiquidation Voluntary Creditors Return Of Final Meeting
3 Jan 2025InsolvencyLiquidation Voluntary Appointment Of Liquidator
3 Jan 2025InsolvencyLiquidation Voluntary Removal Of Liquidator By Court
10 Oct 2024InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
22 Apr 2025 Gazette

Gazette Dissolved Liquidation

22 Jan 2025 Insolvency

Liquidation Voluntary Creditors Return Of Final Meeting

3 Jan 2025 Insolvency

Liquidation Voluntary Appointment Of Liquidator

3 Jan 2025 Insolvency

Liquidation Voluntary Removal Of Liquidator By Court

10 Oct 2024 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

12 months ago on 22 Apr 2025

Liquidation Voluntary Creditors Return Of Final Meeting

1 years ago on 22 Jan 2025

Liquidation Voluntary Appointment Of Liquidator

1 years ago on 3 Jan 2025

Liquidation Voluntary Removal Of Liquidator By Court

1 years ago on 3 Jan 2025

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

1 years ago on 10 Oct 2024